|
|
|
|
Erectile dysfunction helped predict cardiac events, death
Erectile dysfunction may represent a symptom of more advanced atherosclerosis and endothelial dysfunction, after data from a substudy involving patients from the ONTARGET and TRANSCEND trials indicated that the condition often predicted cardiac events and death...
|
|
|
Erectile Dysfunction Ups Death Risk In Male Heart Patients
A study led by German researchers found that erectile dysfunction was a strong predictor of death from all causes as well as death from heart attack, stroke and heart failure in men with cardiovascular disease.You can read about the findings in a paper...
|
|
|
New option for cardio protection
Antihypertensive agent Micardis (telmisartan) 80mg has been approved for the prevention of cardiovascular morbidity and mortality in patients with vascular disease or high-risk diabetes.Pharmacists can now advise patients 55 years or older with a...
|
|
|
Astellas Pharma Withdraws Application For Type 2 Diabetes Drug
Astellas Pharma has withdrawn the application for approval of additional indication for type 2 diabetic incipient nephropathy for 'Micardis tablets'(generic name: telmisartan), angiotensin II receptor blocker which is co-promoted with Nippon Boehringer...
|
|
|
Withdrawn application for approval of additional indication for type 2 diabetic incipient nephropathy for 'Mic
- Astellas Pharma Inc.(Astellas Headquarters: Chuo-ku, Tokyo; President & CEO: Masafumi Nogimori) announced today the withdrawal of the application for approval of additional indication for type 2 diabetic incipient nephropathy for MicardisTablets...
|
